Jennifer Ko retweeted
A snowfall in northern Ohio inspired a cancer patient's daughter to write a message to her mom in the fresh snow outside her hospital room at the Cleveland Clinic cnn.it/2tZZ6fV
Jennifer Ko retweeted
Fecal #microbiome transplantation or probiotic therapy extends the lifespan and improves the health status of progeroid mice, suggesting a link between the gut microbiota and aging | go.nature.com/2YnIGeD
Jennifer Ko retweeted
#VisualAbstract: Trial shows pembrolizumab adjuvant therapy effective in increasing recurrence-free survival in patients with resected stage III #melanoma.
Jennifer Ko retweeted
A vaccine based on induced pluripotent stem cells mimicking the expression of tumour-cell antigens induces significant antitumour immune responses in mouse models. [N&V on this @CellStemCell paper: sciencedirect.com/science/ar…]
nature.com/articles/s41551-0…
Jennifer Ko retweeted
In Opinion
Michael Hayden, the former director of the CIA, writes, "We in the intelligence world have dealt with obstinate and argumentative presidents through the years. But we have never served a president for whom ground truth really doesn’t matter."
nyti.ms/2KqizJY
Replying to @FunchainMD
@FunchainMD discussing the mechanisms that translate into years saved for #melanoma in the new era of #Immunotherapy #CCFDerm18
Jennifer Ko retweeted
.@JenniferKo79 on rational molecular analysis of melanoma that is clinically comprehensive and saves precious tissue #CCFDerm18
Jennifer Ko retweeted
Excited for #USCAP2018!! Come attend our platform on cutaneous sarcomas and their mimics with sr. authors @JenniferKo79 and @SteveBillingsMD at #dermpath platform on Tues 130-145 pm VCC West 202-204 @TheUSCAP #vancouver #sarcoma @CLEClinicLabs @CreightonSOM – at Omaha, NE
Jennifer Ko retweeted
Spindle cell lipoma CAN occur in women (14% of cases), and in women they are often in extremities rather than shawl area. -@SteveBillingsMD. His @amjsurgpathol paper w @JenniferKo79: ncbi.nlm.nih.gov/m/pubmed/28…. #USCAP2018 #pathology #BSTpath
Propranolol for Off-label Treatment of Patients With Melanoma ja.ma/2FNvMhq
Jennifer Ko retweeted
Leisure-time physical activity was associated with lower risks of many cancer types with greatest effects for cancers of the
- Esophagus (HR, 0.58; 95% CI, 0.37-0.89)
- Liver (HR, 0.73; 95% CI, 0.55-0.98) and
- Lung (HR, 0.74; 95% CI, 0.71-0.77)
ja.ma/2G6y5M2
Jennifer Ko retweeted
Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling | Modern Pathology nature.com/articles/s41379-0…
Jennifer Ko retweeted
High response rate (72%) & tolerability for trial of #cetuximab w modified FOLFOXIRI, then maint cetux or #bevacizumab for pts w/unresectable RAS & BRAF wild type metastatic #ColorectalCancer. ja.ma/2C0dDLe #GICSM
Jennifer Ko retweeted
When #genomics and #immunotherapy interact, it’s not just MMR deficiency anymore - extraordinary response in SMARCA4 mutant cancers xitter.gq/vanallenlab/status/965…
Doctors Said Immunotherapy Would Not Cure Her Cancer. They Were Wrong. nyti.ms/2C6gTVj --> @ginakolata @nytimes on frontiers of cancer immunotherapy, including @VanAllenLab cameo whereby I reveal our lab motto :) @DanaFarber @broadinstitute
Jennifer Ko retweeted
One challenge in cancer prevention is missing the window of opportunity to test for cancer predisposition genes for young people diagnosed with cancer and enact prevention going forward -Patricia Ganz #SurvOnc18
Jennifer Ko retweeted
MRA Applauds FDA Approval of Nivolumab to Reduce the Risk of Melanoma Returning After Surgery goo.gl/7nCeLz
Jennifer Ko retweeted
Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors ja.ma/2hDtyGt
Jennifer Ko retweeted
Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors ja.ma/2hDsEK5
Jennifer Ko retweeted
Important step in Cancer #PrecisionMedicine - FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors mskcc.org/blog/fda-authorize…






























